These findings strongly point toward a cell-autonomous defect within Pax5+/− preleukemic cells and further reinforce the view of etiologic variation in leukemia development among different B-ALL molecular subtypes. This evidence concerns the gene PAX5 and precursor B-cell acute lymphoblastic leukemia.